Idiopathic membranous nephropathy: Clinical and histologic prognostic features and treatment patterns over time at a tertiary referral center

American Journal of Nephrology

Volumn 36, Issue 1, 2012, Pages 78-89

  Sprangers, Ben ^a   Bomback, Andrew S ^a   Cohen, Scott D ^a   Radhakrishnan, Jai ^a   Valeri, Anthony ^a   Markowitz, Glen S ^b   D'Agati, Vivette ^b   Appel, Gerald B ^a,c  

^a Division of Nephrology   (United States)

^b College of Physicians and Surgeons ^*  (United States)

^c Department of Medicine   (United States)

Author keywords

Corticosteroids; End stage renal disease; Idiopathic membranous nephropathy; Impaired renal function

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ECULIZUMAB; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; RACE; REMISSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; TERTIARY HEALTH CARE; TREATMENT OUTCOME;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; REFERRAL AND CONSULTATION; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS; UNITED STATES;

EID: 84862734247     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000339628     Document Type: Article

References (34)

1. Rivera F, Lopez-Gomez JM, Perez-Garcia R: Clinicopathologic correlations of renal pa-thology in Spain. Kidney Int 2004; 66:898-904. (Pubitemid 39120989)
2. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P: Distribution of primary renal dis-eases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international com-parative study. Am J Kidney Dis 2000; 35: 157-165. (Pubitemid 30027256)
3. Cattran D: Management of membranous ne-phropathy: when and what for treatment. J Am Soc Nephrol 2005; 16:1188-1194. (Pubitemid 41716503)
4. Dumoulin A, Hill GS, Montseny JJ, Meyrier A: Clinical and morphological prognostic factors in membranous nephropathy: signif-icance of focal segmental glomerulosclero-sis. Am J Kidney Dis 2003; 41:38-48. (Pubitemid 36043350)
5. Gupta R, Sharma A, Mahanta PJ, Jacob TG, Agarwal SK, Roy TS, Dinda AK: Focal seg-mental glomerulosclerosis in idiopathic membranous glomerulonephritis: a clini -co-pathological and stereological study. Nephrol Dial Transplant 2010; 25:444-449.
6. Unver S, Haholu A, Atasoyu EM, Karatas M, Akcan R, Evrenkaya TR: A rare complication of idiopathic membranous nephropathy: crescentic transformation. Ren Fail 2008; 30: 573-575. (Pubitemid 351874059)
7. Koethe JD, Gerig JS, Glickman JL, Sturgill BC, Bolton WK: Progression of membranous nephropathy to acute crescentic rapidly pro-gressive glomerulonephritis and response to pulse methylprednisolone. Am J Nephrol 1986; 6:224-228. (Pubitemid 16022973)
8. James SH, Lien YH, Ruffenach SJ, Wilcox GE: Acute renal failure in membranous glo-merulonephropathy: a result of superim-posed crescentic glomerulonephritis. J Am Soc Nephrol 1995; 6:1541-1546. (Pubitemid 26183537)
9. Singh A, Arif F, Mangat S, Ames R, Douglas C: Quiz page. Acute cellular crescentic glo-merulonephritis in association with anti-glomerular basement membrane disease and superimposed membranous nephropathy. Am J Kidney Dis 2004; 43:A48.e1.
10. Suwabe T, Ubara Y, Tagami T, Sawa N, Hoshino J, Katori H, Takemoto F, Hara S, Aita K, Hara S, Takaichi K: Membranous glomerulopathy induced by myeloperoxi-dase-anti-neutrophil cytoplasmic antibody-related crescentic glomerulonephritis. In-tern Med 2005; 44: 853-858. (Pubitemid 41263833)
11. Hall AM, Symington EM, Sampson SA, Kwan JT: Crescentic transformation of membra-nous glomerulopathy: a reversible condition. Nephrol Dial Transplant 2006; 21: 1136-1137.
12. Chang A, Aneziokoro O, Meehan SM, Quigg RJ: Membranous and crescentic glomerulo-nephritis in a patient with anti-nuclear and anti-neutrophil cytoplasmic antibodies. Kidney Int 2007; 71: 360-365. (Pubitemid 46227096)
13. Troyanov S, Roasio L, Pandes M, Herzen-berg AM, Cattran DC: Renal pathology in idiopathic membranous nephropathy: a new perspective. Kidney Int 2006; 69: 1641-1648.
14. Perna A, Schieppati A, Zamora J, Giuliano GA, Braun N, Remuzzi G: Immunosuppres-sive treatment for idiopathic membranous nephropathy: a systematic review. Am J Kid-ney Dis 2004; 44: 385-401. (Pubitemid 39164615)
15. Shiiki H, Saito T, Nishitani Y, Mitarai T, Yo-rioka N, Yoshimura A, Yokoyama H, Nishi S, Tomino Y, Kurokawa K, Sakai H: Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Ja-pan. Kidney Int 2004; 65:1400-1407. (Pubitemid 38406980)
16. Bazzi C, Petrini C, Rizza V, Arrigo G, DAmico G: A modern approach to selectiv-ity of proteinuria and tubulointerstitial damage in nephrotic syndrome. Kidney Int 2000; 58: 1732-1741.
17. Pei Y, Cattran D, Greenwood C: Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis. Kidney Int 1992; 42: 960-966.
18. Cattran DC, Pei Y, Greenwood CM, Ponti-celli C, Passerini P, Honkanen E: Validation of a predictive model of idiopathic membra-nous nephropathy: its clinical and research implications. Kidney Int 1997; 51: 901-907. (Pubitemid 27157980)
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equa-tion. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470. (Pubitemid 29135798)
20. Ehrenreich T, Porush JG, Churg J, Garfinkel L, Glabman S, Goldstein MH, Grishman E, Yunis SL: Treatment of idiopathic membra-nous nephropathy. N Engl J Med 1976; 295: 741-746.
21. Jennette JC, Iskandar SS, Dalldorf FG: Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int 1983; 24: 377-385. (Pubitemid 13023908)
22. Schieppati A, Mosconi L, Perna A, Mecca G, Bertani T, Garattini S, Remuzzi G: Prognosis of untreated patients with idiopathic mem-branous nephropathy. N Engl J Med 1993; 329: 85-89. (Pubitemid 23188821)
23. Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, Joshi K, Sakhuja V: A random-ized, controlled trial of steroids and cyclo-phosphamide in adults with nephrotic syn-drome caused by idiopathic membranous nephropathy. J Am Soc Nephrol 2007; 18: 1899-1904. (Pubitemid 46870326)
24. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, Sasdelli M, Redael- li B, Grassi C, Pozzi C: A 10-year follow-up of a randomized study with methylpredniso- lone and chlorambucil in membranous nephropathy. Kidney Int 1995; 48:1600-1604.
25. Polanco N, Gutierrez E, Covarsi A, Ariza F, Carreno A, Vigil A, Baltar J, Fernandez-Fresnedo G, Martin C, Pons S, Lorenzo D Bernis C, Arrizabalaga P, Fernandez-Juarez G, Barrio V, Sierra M, Castellanos I, Espino-sa M, Rivera F, Oliet A, Fernandez-Vega F, Praga M: Spontaneous remission of nephrot-ic syndrome in idiopathic membranous ne-phropathy. J Am Soc Nephrol 2010; 21:697-704.
26. Barr RG, Seliger S, Appel GB, Zuniga R DAgati V, Salmon J, Radhakrishnan J: Prog-nosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity Nephrol Dial Transplant 2003; 18: 2039-2046. (Pubitemid 37220309)
27. Contreras G, Lenz O, Pardo V, Borja E, Cely C, Iqbal K, Nahar N, de La CC, Hurtado A, Fornoni A, Beltran-Garcia L, Asif A, Young L, Diego J, Zachariah M, Smith-Norwood B: Outcomes in African Americans and His- panics with lupus nephritis. Kidney Int 2006; 69:1846-1851. (Pubitemid 43739214)
28. Isenberg D, Appel GB, Contreras G, Dooley MA, Ginzler EM, Jayne D, Sanchez-Guerre-ro J, Wofsy D, Yu X, Solomons N: Influence of race/ethnicity on response to lupus ne-phritis treatment: the ALMS study. Rheuma-tology (Oxford) 2010; 49:128-140.
29. Korbet SM, Schwartz MM, Evans J, Lewis EJ: Severe lupus nephritis: racial differences in presentation and outcome. J Am Soc Nephrol 2007; 18: 244-254. (Pubitemid 46070148)
30. Korbet SM, Genchi RM, Borok RZ, Schwartz MM: The racial prevalence of glomerular le-sions in nephrotic adults. Am J Kidney Dis 1996; 27:647-651. (Pubitemid 26135836)
31. Fakhouri F, Bocquet N, Taupin P, Presne C, Gagnadoux MF, Landais P, Lesavre P, Chauveau D, Knebelmann B, Broyer M, Grunfeld JP, Niaudet P: Steroid-sensitive ne-phrotic syndrome: from childhood to adult-hood. Am J Kidney Dis 2003; 41:550-557. (Pubitemid 36278371)
32. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC: Idiopathic membranous ne-phropathy: definition and relevance of a par-tial remission. Kidney Int 2004; 66:1199-1205. (Pubitemid 39121029)
33. Coggins CH: Adult minimal change ne-phropathy: experience of the collaborative study of glomerular disease. Trans Am Clin Climatol Assoc 1986; 97:18-26.
34. Cattran DC, Delmore T, Roscoe J, Cole E, Cardella C, Charron R, Ritchie S: A random-ized controlled trial of prednisone in pa-tients with idiopathic membranous ne-phropathy. N Engl J Med 1989; 320:210-215. (Pubitemid 19034146)